Advanced search
Publication Cover
Journal of Dietary Supplements Volume 21, 2024 - Issue 4
Submit an article Journal homepage
63
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Effects of a Nutraceutical Multicompound, with Probiotics, Hericium, PEA, and Undaria in Patients with Irritable Bowel Syndrome

Antonio Romano,a Gastroenterology Private Practitioner, GF. Medical Center, Pisa, ItalyCorrespondence[email protected]
View further author information
, MD,
Linda Balestrini,b Laboratori Aliveda srl, Crespina Lorenzana, Pisa, ItalyView further author information
, PhD,
Giulia Della Scala,b Laboratori Aliveda srl, Crespina Lorenzana, Pisa, ItalyView further author information
, PhD,
Lucia Chico,b Laboratori Aliveda srl, Crespina Lorenzana, Pisa, ItalyView further author information
, PhD,
Alessio Bertini,c General Practitioner, Montemurlo, Prato, ItalyView further author information
, MD,
Matilde Cangioli,d General Practitioner, Prato, ItalyView further author information
, MD,
Federico Ciapparelli,e General Practitioner, Livorno, ItalyView further author information
, MD,
Enzo Ciardella,f General Practitioner, Pisa, ItalyView further author information
, MD,
Claudia Congestrí,f General Practitioner, Pisa, ItalyView further author information
, MD,
Valentina Dinelli,g General Practitioner, Lucca, ItalyView further author information
, MD,
Fabio Donati,e General Practitioner, Livorno, ItalyView further author information
, MD,
Massimo Ficini,e General Practitioner, Livorno, ItalyView further author information
, MD,
Cecilia Giovanetti,e General Practitioner, Livorno, ItalyView further author information
, MD,
Federico Nannicini,d General Practitioner, Prato, ItalyView further author information
, MD,
Alessandro Pasquali,h General Practitioner, Pistoia, ItalyView further author information
, MD &
Andrea Pieraccini,h General Practitioner, Pistoia, ItalyView further author information
, MD show all
Pages 451-461 | Published online: 08 Jan 2024

References

  • Barbara G, Cremon C, Bellini M, Corsetti M, Di Nardo G, Falangone F, Fuccio L, Galeazzi F, Iovino P, Sarnelli G, et al. 2023. Italian guidelines for the management of irritable bowel syndrome: joint consensus from the Italian societies of: gastroenterology and endoscopy (SIGE), neurogastroenterology and motility (SINGEM), hospital gastroenterologists and endoscopists (AIGO), digestive endoscopy (SIED), general medicine (SIMG), gastroenterology, hepatology and pediatric nutrition (SIGENP) and pediatrics (SIP). Dig Liver Dis. 55(2):187–207. doi: 10.1016/j.dld.2022.11.015.
  • Black CJ, Ford AC. 2020. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat Rev Gastroenterol Hepatol. 17(8):473–486. doi: 10.1038/s41575-020-0286-8.
  • Chey WD, Kurlander J, Eswaran S. 2015. Irritable bowel syndrome: a clinical review. Jama. 313(9):949–958. doi: 10.1001/jama.2015.0954.
  • Diling C, Chaoqun Z, Jian Y, Jian L, Jiyan S, Yizhen X, Guoxiao L. 2017. Immunomodulatory activities of a fungal protein extracted from Hericium erinaceus through regulating the gut microbiota. Front Immunol. 8:666. doi: 10.3389/fimmu.2017.00666.
  • Drossman DA, Hasler WL. 2016. Rome IV—functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 150(6):1257–1261. doi: 10.1053/j.gastro.2016.03.035.
  • Ford AC, Harris LA, Lacy BE, Quigley EM, Moayyedi P. 2018. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Aliment Pharmacol Ther. 48(10):1044–1060. doi: 10.1111/apt.15001.
  • Gwee KA. 2005. Irritable bowel syndrome in developing countries–a disorder of civilization or colonization? Neurogastroenterol Motil. 17(3):317–324. doi: 10.1111/j.1365-2982.2005.00627.x.
  • Jin W, Yang L, Yi Z, Fang H, Chen W, Hong Z, Zhang Y, Zhang G, Li L. 2020. Anti-inflammatory effects of fucoxanthinol in LPS-induced RAW264. 7 cells through the NAAA-PEA pathway. Mar Drugs. 18(4):222. doi: 10.3390/md18040222.
  • Peng L, Li ZR, Green RS, Holzman IR, Lin J. 2009. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr. 139(9):1619–1625. doi: 10.3945/jn.109.104638.
  • Petrosino S, Di Marzo V. 2017. The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations. Br J Pharmacol. 174(11):1349–1365. doi: 10.1111/bph.13580.
  • Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, Mareya SM, Shaw AL, Bortey E, Forbes WP; TARGET Study Group. 2011. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 364(1):22–32. doi: 10.1056/NEJMoa1004409.
  • Rezaie A, Heimanson Z, McCallum R, Pimentel M. 2019. Lactulose breath testing as a predictor of response to rifaximin in patients with irritable bowel syndrome with diarrhea. Am J Gastroenterol. 114(12):1886–1893. doi: 10.14309/ajg.0000000000000444.
  • Rousseaux C, Thuru X, Gelot A, Barnich N, Neut C, Dubuquoy L, Dubuquoy C, Merour E, Geboes K, Chamaillard M, et al. 2007. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med. 13(1):35–37. doi: 10.1038/nm1521.
  • Satoh T, Izumi H, Iwabuchi N, Odamaki T, Namba K, Abe F, Xiao JZ. 2016. Bifidobacterium breve prevents necrotising enterocolitis by suppressing inflammatory responses in a preterm rat model. Benef Microbes. 7(1):75–82. doi: 10.3920/BM2015.0035.
  • Van den Houte K, Carbone F, Pannemans J, Corsetti M, Fischler B, Piessevaux H, Tack J. 2019. Prevalence and impact of self-reported irritable bowel symptoms in the general population. United European Gastroenterol J. 7(2):307–315. doi: 10.1177/2050640618821804.
  • Wang H, Zhang W, Zuo L, Zhu W, Wang B, Li Q, Li J. 2013. Bifidobacteria may be beneficial to intestinal microbiota and reduction of bacterial translocation in mice following ischaemia and reperfusion injury. Br J Nutr. 109(11):1990–1998. doi: 10.1017/S0007114512004308.
  • Wong CB, Odamaki T, Xiao JZ. 2019. Beneficial effects of Bifidobacterium longum subsp. longum BB536 on human health: Modulation of gut microbiome as the principal action. J Funct Foods. 54:506–519. doi: 10.1016/j.jff.2019.02.002.
  • Yang Y, Zhao C, Diao M, Zhong S, Sun M, Sun B, Ye H, Zhang T. 2018. The prebiotic activity of simulated gastric and intestinal digesta of polysaccharides from the Hericium erinaceus. Molecules. 23(12):3158. doi: 10.3390/molecules23123158.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.